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Neurotransmitter synthesis in poststroke cortical
neurogenesis in adult rats
Weigang Gu a,b,⁎, Chao Gu a, Wei Jiang a, Per Wester aa Umeå Stroke Center, Department of Public Health and Clinical Medicine, Medicine, University of Umeå, S-901 87Umeå, Sweden
b Department of Clinical Neuroscience and Neurology, University of Umeå, S-901 87 Umeå, SwedenReceived 23 September 2009; received in revised form 11 December 2009; accepted 16 December 2009Abstract Neurogenesis occurs in the cerebral cortex of adult rats after focal cerebral ischemia. Whether or not the newborn
neurons could synthesize neurotransmitters is unknown. To elucidate such a possibility, a photothrombotic ring stroke model
with spontaneous reperfusion was induced in adult male Wistar rats. The DNA duplication marker BrdU was repeatedly injected,
and the rats were sacrificed at various times after stroke. To detect BrdU nuclear incorporation and various neurotransmitters,
brain sections were processed for single/double immunocytochemistry and single/double/triple immunofluorescence.
Stereological cell counting was performed to assess the final cell populations. At 48 h, 5 days, 7 days, 30 days, 60 days and 90
days after stroke, numerous cells were BrdU-immunolabeled in the penumbral cortex. Some of these were doubly
immunopositive to the cholinergic neuron-specific marker ChAT or GABAergic neuron-specific marker GAD. As analyzed by 3-D
confocal microscopy, the neurotransmitters acetylcholine and GABA were colocalized with BrdU in the same cortical cells. In
addition, GABA was colocalized with the neuron-specific marker Neu N in the BrdU triple-immunolabeled cortical cells. This
study suggests that the newborn neurons are capable of synthesizing the neurotransmitters acetylcholine and GABA in the
penumbral cortex, which is one of the fundamental requisites for these neurons to function in the poststroke recovery.
© 2009 Elsevier B.V. All rights reserved.Introduction
Ischemic stroke ranks at the top as far as disabling patients in
their adult life. The outcome of ischemic stroke depends
largely on the severity and duration of the local cerebral
blood flow reduction. Early and even late spontaneous
reperfusion is associated with a favorable neurological
outcome after ischemic stroke in humans (von Kummer
et al., 1995). After ischemic stroke, neurological improve-Abbreviations: BrdU, 5-bromodeoxyuridine; Ach, acetylcholine;
ChAT, choline acetyl transferase; GABA, gamma-aminobutyric acid;
GAD, glutamic acid decarboxylase.
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doi:10.1016/j.scr.2009.12.001ment occurs in various degrees, starting days after the stroke
and lasting up to 18 months (Hankey et al., 2007). The early
neurological improvements may be explained by the emis-
sion of ischemic edema, decompression of the intact brain
tissue, and the resuscitation of ischemic penumbra. For long-
term neurological recovery, neuroplasticity and cell regen-
eration may play important roles (Johansson, 2007).
Focal cerebral ischemia induces neurogenesis in the
penumbral cerebral cortex, which has been reported in
adult rats after photothrombotic ring stroke (Gu et al., 2000)
and after middle cerebral artery occlusion (Jiang et al.,
2001; Jin et al., 2003), and in adult mice after middle
cerebral artery occlusion (Tsai et al., 2006). The photo-
thrombotic ring stroke model features a large anatomically
predefined cortical penumbra in the somatosensory cortex
(Wester et al., 1995). In this stroke model, an inner core,.
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encroached by a radially expanding annular ischemic core,
thus simulating stroke-in-evolution. Microvascular platelet
thrombi appear in the cortical lesion (Gu et al., 1999b;
Wester et al., 1995), reminiscent of clinical thrombo-
embolic stroke. Delayed, but consistent, spontaneous
reperfusion of the cortical penumbra can be presaged in
the “ring” model by manipulation of the irradiating laser
beam intensity (Gu et al., 1999a). Consequently, local
cerebral blood flow (CBF) in the penumbra decreases to
59–34–26–33% of baseline values at 1–2–24–48 h after
stroke induction, and then gradually recovers to 56–87% of
baseline values at 72–96 h (Gu et al., 1999c). Quick
induction of immediate early genes (Johansson et al.,
2000) is followed by a prevalence of neuronal necrosis and
apoptosis at 24–48 h postischemia in the penumbral cortex
(Gu et al., 2009, 1999b; Hu et al., 2002). Early angiogenesis
and the presence of blood elements within the newly
formed vessels (Gu et al., 2001) may suggest functional
angiogenesis (Gu et al., 1999b). Concurrent with the
apoptotic and necrotic cell death in the penumbral cortex,
local cells are induced to proliferate and divide, generating
newborn neurons (Gu et al., 2009), which contribute to the
poststroke cortical neurogenesis (Gu et al., 2000). Neurite-
like structures are readily immunolabeled by various
classical neuron markers in the newborn neurons that
survive up to 3–18 months poststroke (Gu et al., 2000;
Jiang et al., 2001). Nevertheless, neither the neuronal
immunolabeling nor the morphological appearance provide
any information about the functional potential of these
newborn neurons. As the interest in endogenous poststrokeFigure 1 (A) Low magnification photograph of BrdU single immu
photothrombotic ring stroke. Two wedge-shaped cortical infarcts
demarcated, between which lays the cortical penumbra. Numerous
cortex and in the cortex near the ring lesion. Scale bar: 532 μm
immunohistochemistry in the cortex at 7 days after stroke. The Ach-im
the GFAP-immunolabeled astrocytes (in black, arrowed). Scale bar
double immunohistochemistry in the cortex at 7 days after stroke. T
are separated from the GFAP-immunolabeled astrocytes (in black, ar
GAD and GFAP double immunohistochemistry in the cortex at 7 days a
arrowhead) are separated from the GFAP-immunolabeled astrocytesneurogenesis grows, a decent study of its functional
potential is warranted. One of the fundamental prerequi-
sites of functional ability for poststroke neurogenesis is that
the newborn neurons should be capable of synthesizing
various neurotransmitters. The present study aims to detect
the possible occurrence of neurotransmitter synthesis in
newborn neurons in adult rat brains after photothrombotic
ring stroke with spontaneous reperfusion.
Results
5-Bromodeoxyuridine (BrdU) single
immunohistochemistry
Widespread BrdU-immunolabeled cells were observed in the
postischemic cerebral cortex, corpus callosum, and dentate
gyrus of the hippocampus ipsilateral to ischemic lesion at 48
h, 5 days, 7 days, 30 days, 60 days, and 90 days after stroke
induction (Fig. 1A). Most of the BrdU-immunolabeled cells
appeared in the cortical penumbra surrounded by the ring-
shaped cortical lesion and its surrounding cortex, and less in
the ring lesion area. These cells were distributed randomly
through cortical layers I to VI. In the cortex contralateral to
the ischemic lesion, a few BrdU-immunopositive cells were
observed. In the sham-operated rats that received the same
repeated BrdU injections as the ischemic groups, a few BrdU-
immunolabeled cells were seen to be randomly scattered in
the bilateral cortex. In the BrdU-negative controls, i.e., the
rats that did not receive any BrdU injections, no BrdU-
immunolabeled cells were observed in the brain sections.nohistochemistry in the rat cerebral cortex at 5 days after the
(ischemic core) representing ring-shaped ischemic lesion are
BrdU-immunolabeled cells (in purple) appear in the penumbral
. (B) High magnification photograph of Ach and GFAP double
munolabeled neurons (in brown, arrowhead) are separated from
: 11 μm. (C) High magnification photograph of ChAT and GFAP
he ChAT-immunolabeled cortical neurons (in brown, arrowhead)
rowed). Scale bar: 11 μm. (D) High magnification photograph of
fter stroke. The GAD-immunolabeled cortical neurons (in brown,
(in black, arrowed). Scale bar: 11 μm.
150 W. Gu et al.Double immunohistochemistry of GFAP and
neurotransmitter markers
In order to examine the specificity of neurotransmitter
markers, double immunohistochemistry of the astrocyte
marker GFAP with one of the neurotransmitter markers
choline acetyltransferase (ChAT), acetylcholine (ACh), glu-
tamic acid decarboxylase (GAD), and gamma-aminobutyric
acid (GABA) was conducted. In the sham-operated and
poststroke brains, ChAT, Ach, GAD, and GABA (Figs. 1B–D)
labeled cortical neurons whereas GFAP labeled astrocytes in
the cerebral cortex.
Double immunolabeling of BrdU and
neurotransmitter markers
To screen a possible colocalization of BrdU with one of the
neurotransmitter markers ChAT, Ach, GAD, and GABA in the
cortical cells, the corresponding double immunohisto-
chemistry experiments were performed. Many neurons
outside the penumbral cortex were immunolabeled by
these neurotransmitter markers. In contrast, the majority
of the cells inside the penumbral cortex were not immuno-
labeled by Ach and GABA. In some cortical cells in which the
cell nuclei were BrdU-immunolabeled, the cytoplasm was
immunopositive to ChAT, Ach, GAD, or GABA. These cells
were randomly distributed in cortical layers II–VI in the
penumbral cortex at 48 h, 5 days, 7 days, 30 days, 60 days,
and 90 days after stroke. In the pannecrotic ischemic
core, such cells were not seen. In order to detect a real
colocalization of BrdU with these neurotransmitters in the
cortical cells, the corresponding double immunofluores-
cence labelings were analyzed by 3-D confocal microscopy.
BrdU was colocalized with the ChAT (Figs. 2A and B), Ach
(Figs. 2C–E), GAD (Fig. 2F), and GABA (Fig. 2G; Figs. 2H–K) in
the same cortical cells at 48 h, 5 days, 7 days, 30 days, 60
days, and 90 days after stroke.
GABA, BrdU, and Neu N triple immunofluorescence
To confirm the neuronal identity of the GABA and BrdU
double-immunolabeled cells in the penumbral cortex, GABA,
BrdU, and Neu N triple immunofluorescence was performed.
Neu N was colocalized with GABA in the same cell in which
the cell nucleus was BrdU triple-immunolabeled (Figs.
2H–K). Neurite-like extensions were sometimes seen in
these cells (Figs. 2H–K).
Cell counting
The cell density of BrdU single-immunopositive cells in the
ischemic cortex was 43,700±18,800 cells/mm3 (M±SD) at
48 h poststroke. It increased to 204,600±105,600 cells/
mm3 (M±SD) at 7 days, and then decreased to 4600±1100
cells/mm3 (M±SD) at 30 days poststroke. At this time, the
density of the BrdU and Ach double-immunopositive cells
was 390±535 cells/mm3, which corresponds to about 8% of
the total BrdU-immunopositive cells in the ischemic
cortex. The density of BrdU and GABA double-immunopositive
cells was 157±187 cells/mm3, which counts for about 3% of
total BrdU-immunopositive cells in the ischemic cortex. Inthe same part of the cortex, the density of the Map-2ab
single-immunopositive neurons was 104,500±30,900 cells/
mm3 (M±SD).Discussion
The most interesting finding of this study is the detection of
the neurotransmitters acetylcholine and GABA in the
newborn neurons in the penumbral cerebral cortex in adult
rats after photothrombotic ring stroke. These data support
further the previous finding that the newborn cells identified
by various classic neuronal markers in the penumbral
cerebral cortex are indeed neurons (Gu et al., 2000, 2009;
Jiang et al., 2001; Jin et al., 2003; Tsai et al., 2006).
In the previous studies of stroke-induced cortical
neurogenesis (Gu et al., 2000; Jiang et al., 2001) and
cortical cell division (Gu et al., 2009), the differentiated
neuronal markers Neu N, Hu, Map-2ab, and β-tubulin III
and the astrocyte marker GFAP are used for the determi-
nation of neuron and astrocyte cell identity. A theoretical
concern with this methodology is that some of these
neuronal markers might be expressed by other cell types
rather than neurons in the postischemic penumbral cortex.
On the other hand, immunolabeling of cortical cells by
these classical neuronal markers does not give any
information about their neurophysiological potential to
function as neurons in the poststroke penumbral cortex.
These issues are addressed in the present study in the
following ways. First, the substrate enzymes ChAT and
GAD, which are essential for the biosynthesis of Ach and
GABA, respectively, are examined. It is well known that
ChAT is exclusively found in cholinergic neurons (Schaevitz
and Berger-Sweeney, 2005), and GAD in GABAergic neurons
in brains (Bedard et al., 2006; Dayer et al., 2005). The
identification of ChAT and BrdU double-immunopositive
cells or GAD and BrdU double-immunolabeled cells has
been a common method for detecting cholinergic or
GABAergic newborn neurons in brains (Bedard et al.,
2006; Dayer et al., 2005). Therefore, the ChAT and BrdU
double-immunolabeled cells and the GAD and BrdU double-
immunopositive cells observed in the present study should
represent newborn cholinergic neurons and GABAergic
neurons. Second, the excitatory neurotransmitter Ach and
the inhibitory neurotransmitter GABA are studied. Being
neurotransmitters, Ach and GABA are synthesized only in
cholinergic and GABAergic neurons in brains. The detection
of Ach and GABA immunoreactivity in the BrdU double-
immunolabeled cells suggests the biosynthesis of
corresponding neurotransmitters in these newborn neurons
(Bedard et al., 2006; Dayer et al., 2005). Third, the
specificity of the neurotransmitter markers used is exam-
ined. The distinct separation of ChAT, Ach, GAD, and
GABA-immunopositive cells from GFAP-immunolabeled cells
in the cortex indicates that these neurotransmitter anti-
bodies label specifically the cholinergic and GABAergic
neurons, rather than astrocytes. Finally, the neuronal
identity of the newborn GABAergic cells is further studied
through GABA, Neu N, and BrdU triple immunofluo-
rescence. The colocalization of Neu N with GABA in the
BrdU triple-immunolabeled cells confirms the neuronal
identity of the newborn cells synthesizing GABA.
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double-immunolabeled cells in the present study agrees
with the notion that the BrdU immunolabeling representsFigure 2 (A) Projection confocal image of ChAT (in red, Alexa F
immunofluorescence in the penumbral cortex at 60 days after st
immunofluorescence in a cell from cortical layer II (framed area in pa
surrounded by ChAT-immunopositive cytoplasm (in red). (C) 3-D con
layer IV of the cortical penumbra at 30 days after stroke. In a large c
DAPI (in blue) is BrdU-immunolabeled (in green), which is surrounde
analysis. Several cells that are counterstained by DAPI (in blue, arrow
(D) 3-D confocal analysis of Ach and BrdU double-channel image from
the cell nucleus (in green) is weak at 30 days after stroke, a phenome
(Gu et al., 2000; Jiang et al., 2001). (E) 3-D confocal analysis of Ach,
penumbra at 90 days after stroke. In a cortical cell, the BrdU-immun
immunopositive cytoplasm (in red) in 3-D analysis. The arrowhead i
immunolabeled (in green) in the cell nucleus counterstained by DAP
triple immunofluorescence in layer III of cortical penumbra at 7 da
arrowed) which is counterlabeled by DAPI (in blue) is surrounded by G
at a DAPI (in blue) counterstained cell nucleus singly immunopositive
double immunofluorescence in layer III of cortical penumbra at 4
immunolabeled (in green, arrowed) that is surrounded by GABA-immu
and Neu N triple immunofluorescence in layer IV of cortical penumbra
Fluor 546), BrdU (in green, Alexa Fluor 488), and Neu N (in blue, Ale
cortical cell (framed) is triple immunolabeled by GABA (in red), Brd
BrdU single-immunolabeled (in green) cortical cell superimposing o
neuron. (I) BrdU single-channel image of the cortical cell framed
arrowed). (J) BrdU and Neu N double-channel image from the same
arrowed) is colocalized with Neu N (in blue) in the same cell in 3-D co
from the same scanning section as panels I–J. The GABA (in red) is col
(arrowed) in 3-D analysis.cell regeneration in the setting of the photothrombotic ring
stroke, in contrast to DNA damage (Kuan et al., 2004). This
is because in the setting of focal cerebral ischemia the CBFluor 546), BrdU (in green, Alexa Fluor 488), and DAPI (in blue)
roke. (B) A section confocal image of ChAT and BrdU double
nel A). A BrdU-immunolabeled cell nucleus (in green, arrowed) is
focal analysis of Ach, BrdU, and DAPI triple-channel image from
ortical cell, the cell nucleus (arrowed) that is counterlabeled by
d by Ach-immunopositive cytoplasm (in red) in the 3-D confocal
head) are not immunolabeled by Ach and BrdU in the same field.
the same scanning plan as panel C. The BrdU immunolabeling in
non that is commonly observed in long-term neurogenesis studies
BrdU, and DAPI triple-channel image from layer III of the cortical
olabeled cell nucleus (in green, arrowed) is surrounded by Ach-
s pointed at a cortical cell in the same field that is BrdU single-
I (in blue). (F) A section confocal image of GAD, BrdU, and DAPI
ys after stroke. A BrdU-immunolabeled cell nucleus (in green,
AD-immunolabeled cytoplasm (in red). The arrowhead is pointed
to BrdU (in green). (G) 3-D confocal analysis of GABA and BrdU
8 h after stroke. In a cortical cell, the cell nucleus is BrdU-
nopositive cytoplasm (in red) in 3-D analysis. (H–K) GABA, BrdU,
at 72 h after stroke. (H) Projection image of GABA (in red, Alexa
xa Fluor 405) triple immunofluorescence at low magnification. A
U (in green), and Neu N (in blue). The arrowhead is pointed at a
n a GABA (in red) and Neu N (in blue) double-immunopositive
in panel H. The cell nucleus is BrdU-immunolabeled (in green,
scanning section as panel I. The BrdU immunolabeling (in green,
nfocal analysis. (K) GABA, BrdU, and Neu N triple-channel image
ocalized with Neu N (in blue) and BrdU (in green) in the same cell
152 W. Gu et al.threshold for neurotransmitter release (corresponding to
40–60% of the baseline CBF) is higher than that of the
membrane threshold (corresponding to 20–40% of the
baseline CBF) beyond which structural damage of the
ischemic tissue occurs (Hossmann, 1994). Timewise, post-
stroke neurotransmitter release occurs earlier than cell
apoptosis and necrosis through which ischemic cell death
takes place. As noted, in the photothrombotic ring stroke
model the local CBF in the cortical penumbra drops to 34%
of the baseline level at 2 h after ischemia (Gu et al.,
1999a). This CBF level is already well below the neuro-
transmitter threshold at which neurotransmitter release is
triggered, while the tissue morphology remains intact (Gu
et al., 1999b). Consequently, as many neurons outside the
cortical penumbra are Ach or GABA single immunopositive,
the majority of cells inside the penumbral cortex are not
Ach or GABA-immunolabeled at 24–48 h after stroke, which
may suggest postischemic neurotransmitter leakage. Some
of the cortical cells are TUNEL-positive, representing
nuclear DNA damage (Gu et al., 2009). On the other
hand, certain cells in the penumbral cortex are induced to
proliferate. They incorporate the DNA duplication marker
BrdU, express various mitosis-specific markers, and finally
divide to generate newborn neurons (Gu et al., 2009). At
this time, Ach and GABA are detected in some cortical cells
that are BrdU doubly immunolabeled in their nuclei, rather
than those that are TUNEL positive. Thus, cell regeneration
concurs with ischemic cell death in the same cortical
penumbra in the setting of photothrombotic ring stroke (Gu
et al., 2009). A 4.7 times increment of BrdU single
immunolabeling in the penumbral cortex is observed at 7
days as compared with that at 48 h postischemia. At 7 days
after ischemia, most of the BrdU-immunolabeled cells in
the ischemic penumbra represent newborn astrocytes,
endothelial cells, and inflammatory cells (Gu et al.,
1999b). At 30 days after stroke, 8.4% of the BrdU-
immunolabeled cells in the penumbral cortex are BrdU
and Ach double immunopositive, and 3.4% of the BrdU-
immunolabeled cells are BrdU and GABA double immuno-
positive. These cells are survived at 90 days after stroke. If
the BrdU nuclear incorporation in the neurons were
resulted from DNA damage, i.e., abortive cell cycle reentry
as seen in the hippocampus after cerebral hypoxia (Kuan et
al., 2004), these neurons should have lost their neurotrans-
mitters and then they should have become damaged in
their nuclear DNA and thus should have been TUNEL
positive, as in contrast to being Ach or GABA immuno-
positive but TUNEL negative. Furthermore, they would
have died shortly of cell apoptosis after stroke, instead of
being able to survive up to 90 days after stroke. Therefore,
the BrdU immunolabeling in the present study speaks for
cell regeneration in the penumbral cortex instead of DNA
damage. Interestingly, GABA is reported to be synthesized
in new interneurons in neocortex and striatum in normal
adult rats (Dayer et al., 2005).
It is conceivable that certain neurons being minimally
damaged in their nuclear DNA, after postischemic neuro-
transmitter release, might incorporate a trivial amount of
BrdU during their DNA repair. However, such a trivial BrdU
incorporation seems hardly detectable by current immuno-
labeling techniques. To our knowledge, long-term survival of
DNA-damaged neurons exhibiting simultaneous BrdU nuclearlabeling and neurotransmitter synthesis has not been
reported. Therefore, the cells in the present observation
are most likely to represent cholinergic and GABAergic
newborn neurons synthesizing the neurotransmitter Ach and
GABA. Nevertheless, the synthesis of the Ach and GABA in the
newborn neurons does not warrant a spontaneous recruit-
ment of these cortical neurons into poststroke neurological
recovery. The functional neurotransmitter release, the
activation of their corresponding receptors, the postrelease
deactivation, and the proper connection of the newborn
neurons with surrounding cells are all important for the
newborn neurons to function. These issues are beyond the
scope of the present study and should be addressed in future
studies.Experimental procedures
Stroke induction
Animal care and all experimental procedures were carried
out in accordance with the European Communities Council
Directive (86/609/EEC), and the experimental protocol was
approved by the Ethics Committee for Animal Research at
Umeå University. The photothrombotic ring stroke model
with spontaneous reperfusion was induced in adult rats as
previously described (Gu et al., 1999a; Wester et al.,
1995). Briefly, adult male Wistar rats weighing 280–340 g
were first anesthetized with 3.5% halothane in an induction
chamber, and then maintained by 2% halothane and a
mixture of 70% nitrous oxide with 30% oxygen delivered
through a closely fitting face mask. Femoral arterial and
venous polyethylene (PE-50) catheters were inserted for
monitoring arterial blood pressure, blood gases, and
glucose and administration of erythrosine B. The rats
were intubated with PE-240 and mechanically ventilated
(Ugo Basile small-animal respirator, Stoelting) with
approximately 1% halothane in a 70:30 mixture of N2O:
O2. Respiratory adjustments were made, when necessary,
to ensure normal arterial blood gases as measured by the
ABL 300 analyzer (Radiometer, Copenhagen, Denmark).
Head temperature and rectal temperature were kept at
37.0–37.5 °C. The rats were mounted on a stereotaxic
frame (David Kopf, Tujunga, CA, USA). The photothrom-
botic ring stroke model with spontaneous reperfusion was
induced on the right parietal skull bone as previously
described (Gu et al., 1999a; Wester et al., 1995). To label
many proliferating cells while minimizing any potential
cellular toxicity, the cell proliferation-specific marker 5-
bromodeoxyuridine (Sigma) was repeatedly administered
intraperitoneally at low doses (10 mg/kg BrdU dissolved in
saline for each injection) (Gratzner, 1982; Gu et al., 2000;
Jiang et al., 2001). The BrdU administration was started
immediately after stroke induction, two times daily, and
ended at 48 h, 5 days, 7 days, and 10 days after stroke
induction. The animals were sacrificed at 48 h, 5 days, 7
days, 30 days, 60 days, and 90 days after stroke (n=4 in
each group) or 7 days after sham operation (Gu et al.,
2000; Jiang et al., 2001) by transcardial perfusion with
37 °C Histochoice tissue fixative or decapitation (Gu et al.,
2000; Jiang et al., 2001). Brains were paraffin-embedded
or quickly frozen at −80 °C.
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Paraffin-embedded coronal brain sections (10 μm thick)
through the lesioned cortex were immunostained according
to the protocol recommended for using the Vector staining
kit (Jiang et al., 2001). Brain sections were deparaffinized in
xylene and dehydrated through graded ethanol series.
Endogenous peroxidase was deactivated by 30 min incuba-
tion in freshly prepared 3% [(v:v)] H2O2:methanol. The
sections were incubated in 2 M HCl in saline for 30 min to
denature the DNA for BrdU detection. Antigen retrieval and
deactivation of the endogenous alkaline phosphatase were
achieved by 3×7 min of boiling in 0.1 M citrate buffer (pH
6.0) in a microwave oven with a 5-min cooling interval.
Single-labeling immunohistochemistry was conducted with
Elite Vectastain ABC-peroxidase-Vector-VIP (Vector Labora-
tories, Burlingame, CA, USA). Double immunohistochemistry
was conducted by sequential detection of the first primary
antibodies with Vectastain ABC-AP-Vector-NovaRed (Vector
Laboratories), and then detection of the second primary
antibodies with Elite Vectastain ABC-peroxidase-Vector-SG
(Vector Laboratories). The primary antibodies used were
DNA duplication marker mouse-anti-BrdU (Becton Dickinson,
San Jose, CA, USA); astrocyte-specific marker mouse-anti-
GFAP (DAKO, A7S, Glostrup, Denmark); rabbit-anti-ChAT
(Chemicon, AB5042, Temecula, CA, USA), rabbit-anti-Ach
(Chemicon, AB5522); rabbit-anti-GAD (Novus Biologicals,
Inc., AB2348, Littleton, CO, USA), rabbit-anti-GABA (Che-
micon, AB5016); the neuron-specific marker mouse anti-Map
2ab (Boehringer Mannheim, Indianapolis, IN, USA). To verify
the specificity of the immunostaining, primary antibodies
were omitted from the staining procedure in a set of control
sections. Naive animals without BrdU injections were used
as anti-BrdU-negative controls (n=4) (Gu et al., 2000; Jiang
et al., 2001).Immunofluorescence cell labeling
Immunofluorescence labeling was performed on 10-μm-thick
frozen brain sections (Gu et al., 2000, 2009; Jiang et al.,
2001). Brain sections were prefixed in 4% paraformaldehyde
for 30 min, and washed twice for 3 min each time in 0.01 M
PBS. For BrdU immunolabeling, the brain sections were
pretreated with 2 M HCl for 30 min to denature DNA. The
slides were immersed in 1% normal goat serum and 1% Triton
X-100 in PBS for 30 min, and then incubated with the first
primary antibody mouse anti-BrdU or rat anti-BrdU overnight
at 4 °C. The specimen was blocked with 5% normal goat
serum for 30 min and incubated with the corresponding
secondary antibody conjugated with Alexa Fluor 488 (Molec-
ular Probes, Eugene, OR, USA) and rinsed with 0.01 M PBS.
When double/triple immunofluorescent labeling was per-
formed, the first primary antibody was detected as noted
above. The second/third primary antibodies, which were
raised in animal species different from the first/second
primary antibodies, were stained with the same procedure as
the first primary antibodies but detected with their
corresponding secondary antibodies conjugated with Alexa
Fluor 546 (Molecular probes) or with Alexa Fluor 546 and
Alexa Fluor 405. The primary antibodies used were DNA
duplication marker mouse-anti-BrdU (Becton Dickinson) andrat anti-BrdU (Accurate Chemical & Scientific Corporation,
Westbury, NY, USA); neuron-specific marker Neu N (Chemi-
con); rabbit-anti-ChAT (Chemicon, AB5042), rabbit-anti-Ach
(Chemicon, AB5522); rabbit-anti-GAD (Novus Biologicals,
Inc., AB2348), rabbit-anti-GABA (Chemicon, AB5016). DAPI
(Molecular Probes) was used to counterstain the nuclear
DNA. To verify the specificity of the immunolabeling,
primary antibodies were omitted from the staining proce-
dure in a set of control experiments. Naive animals without
BrdU injections were used as anti-BrdU-negative controls
(n=4) (Gu et al., 2000; Jiang et al., 2001).
Confocal microscopy
Double/triple immunofluorescent brain sections were
scanned with a laser scanning confocal microscope (Nikon
Microscope ECLIPSE E800, Japan). In order to eliminate the
potential bleed-through between different fluorophores, a
separate fluorophore detection procedure was employed in
the scanning, i.e., one employing sequential laser excitation
in each optical plane (Gu et al., 2000, 2009; Jiang et al.,
2001). When one fluorophore was scanned, all other channels
were closed (i.e., zeroed). Confocal parameters (e.g.,
pinhole sizes) were adjusted to minimize the thickness of
the optical sections.
Stereological cell counting
Three coronal brain sections through the ischemic lesion
were randomly selected from each brain at 48 h, 7 days, and
30 days poststroke (n=3 in each group) (Gu et al., 2000,
2009). To assess the final cell populations, brain sections
from the 30-day poststroke group were immunostained for
BrdU and Ach, or BrdU and GABA double immunolabeling, or
for Map-2ab single immunolabeling and counted under a
CAST-Grid system (Olympus, Albertslund, Denmark)
(Gundersen et al., 1988). To get a dynamic overview on
the poststroke cell proliferation, BrdU single immunostaining
was also performed in the 48 h and 7-day poststroke groups
and brain sections were counted under the CAST-Grid
system. The region of interest was defined as the cortical
region confined between two artificial delineations from the
lateral and interior edges of the ischemic ring lesion down to
the corpus callosum as described previously (Gu et al., 2009).
Both the ischemic cortical ring lesion and the centrally
located penumbra were thus included in the stereological
cell counting.
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